Online ISSN: 1949-2553
www.oncotarget.com
About Oncotarget
Our mission is to make scientific results rapidly and widely available. We seek to maximize the impact of research via insightful review, to enable exceptional discoveries to be shared quickly, to eliminate the border between specialties, to link different fields of biomedical science, and to foster application of basic and clinical science to fight disease.

LEARN MORE ABOUT ONCOTARGET

EMT Resistance in Cancer Cells and Two Potential Causes

Oncotarget

October 21, 2021
Researchers used mathematical modeling to investigate mechanisms that drive the elusive phenomenon of cancer cell resistance to epithelial-mesenchymal transition (EMT). continue reading »

New Study: ATR Inhibition Reverses Chemo-Resistance in Subset of Cells

Oncotarget

October 13, 2021
Ataxia telangiectasia and Rad3 (ATR) inhibition was targeted in an attempt to overcome temozolomide (TMZ) resistance in a subset of MGMT-negative and MMR-proficient cancer cell lines. continue reading »

Table of Contents: Oncotarget’s Volume 12, Issue #21

Oncotarget

October 12, 2021
Read short summaries of the latest oncology-focused research published in this week’s issue of Oncotarget, Volume 12, Issue 21. continue reading »

Exploration of Gene Editing In The Tumor Setting

Oncotarget

October 5, 2021
Researchers repurposed CRISPR/Cas9 epigenetic editing technology in hopes of characterizing transcriptional changes and effects in different tumor settings. continue reading »

Trending With Impact: Unconventional Method Effectively Targets NSCLC

Oncotarget

September 30, 2021
In a trending paper published by Oncotarget, researchers developed a divergent strategy to treat non-small cell lung cancer (NSCLC). continue reading »